Loopbaan van Gregory M. Torre
Eerdere bekende functies van Gregory M. Torre
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SELLAS LIFE SCIENCES GROUP, INC. | Directeur/Bestuurslid | 29-12-2017 | 27-04-2018 |
| Hoofd Techniek/Wetenschap/O&O | 29-12-2017 | 27-04-2018 | |
| Algemeen Adviseur | 29-12-2017 | 27-04-2018 | |
| NPS PHARMACEUTICALS, INC. | Algemeen Adviseur | 01-02-2006 | 31-07-2007 |
Elusys Therapeutics, Inc.
 Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | Algemeen Adviseur | 22-12-2010 | - |
| Corporate Officer/Principal | - | - |
Opleiding van Gregory M. Torre
| St. John's University | Doctorate Degree |
| Brooklyn Law School | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| General Counsel | 3 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SELLAS LIFE SCIENCES GROUP, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
Elusys Therapeutics, Inc.
Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | Health Technology |
- Beurs
- Insiders
- Gregory M. Torre
- Ervaring
